Institut national de la santé et de la recherche médicale (INSERM), France
DNDi Board Chair
Dr Marie-Paule Kieny is Director of Research at Institut national de la santé et de la recherche médicale (INSERM), Paris, France. In 2017, Dr Kieny was elected as Chair of the Board for two global health initiatives: DNDi and The Medicines Patent Pool Foundation (MPPF). She is also an independent director of bioMérieux.
Between October 2010 and June 2017, Dr Kieny served as Assistant Director-General at the World Health Organization, with a broad portfolio covering Health Systems and Innovation. In addition to her work on Health Systems, from 2014-2016, Dr Kieny was in charge of Ebola R&D for WHO. Between May 2015 and her departure from WHO, she led the implementation of the WHO R&D Blueprint for action against epidemics. Her first role at WHO was with the Special Programme for Research and Training in Tropical Diseases in 2001. She directed the WHO Initiative for Vaccine Research since its inception in 2001. In 2009-2010 she led the WHO Pandemic Influenza Deployment Initiative. Before her time at WHO, Dr Kieny held top research positions in the public and private sectors in France. The positions included Assistant Scientific Director of Transgene SA and Director of Research and Head of the Hepatitis C Virus Molecular Virology Group at the Institute of Virology at INSERM.
Marie-Paule Kieny influenced the strategic development of several organizations through participation in their Executive Board. She also chaired the Scientific Advisory Board of many international organizations.
Dr Kieny directed the research of many doctoral candidates and undergraduates. She has published over 250 articles and reviews, mainly in the areas of infectious diseases, immunology, vaccinology and health systems.
Dr Kieny studied Economics, earned a DEA, an ENSAM (Diplôme d’Agronomie Approfondie) and received her PhD from the University of Montpellier. She earned a d’Habilitation à Diriger des Recherches, from the University of Strasbourg, took an executive course in Global Health Diploma at the Graduate Institute in Geneva and took part in the Executive High Performance Boards programme of the International Institute for Management Development (IMD) in Lausanne.